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SUMMARY
1. The serotonin type 1A (5-HT,A) receptors are members of a superfamily of seven
transmembrane domain receptors that couple to GTP-binding regulatory proteins (G-
proteins). We have studied the modulation of agonist binding to 5-HT,A receptors from
bovine hippocampus by metal ions and guanine nucleotide.
2. Bovine hippocampal membranes containing the 5-HT,A receptor were isolated.
These membranes exhibited high-affinity binding sites for the specific agonist [3H]OH-
DPAT.
3. The agonist binding is inhibited by monovalent cations Na+, K*, and Li* in a
concentration-dependent manner. Divalent cations such as Ca2+, Mg2*, and Mn!*, on the
other hand, show more complex behavior and induce enhancement of agonist binding up
to a certain concentration. The effect of the metal ions on agonist binding is strongly
modulated in the presence of GTP--y-S, a nonhydrolyzable analogue of GTP, indicating
that these receptors are coupled to G-proteins.
4. To gain further insight into the mechanisms of agonist binding to bovine hippocam-
pal 5-HT|A receptors under these conditions, the binding affinities and binding sites have
been analyzed by Scatchard analysis of saturation binding data. Our results are relevant
to ongoing analyses of the overall regulation of receptor activity for G-protein-coupled
seven transmembrane domain receptors.
KEY WORDS: 5-HT,A receptor; metal ions; bovine hippocampus; OH-DPAT; Scatchard
analysis; guanine nucleotide.
INTRODUCTION
Serotonin (5-hydroxytryptamine; 5-HT) is an intrinsically fluorescent, biogenic
amine which acts as a neurotransmitter and is found in a wide variety of sites in
the central and peripheral nervous systems (Jacobs and Azmitia, 1992; Chattopad-
hyay et al, 1996). It is present in a variety of organisms, ranging from humans to
species with primitive nervous systems such as worms (Hen, 1992), and mediates
a variety of physiological responses in distinct cell types. Serotonergic signaling
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appears to play a key role in the generation and modulation of various cognitive
and behavioral functions including sleep, mood, pain, addiction, locomotion, sexual
activity, depression, anxiety, alcohol abuse, aggression, and learning (Chojnacka-
Wojcik et al, 1991; Wilkinson and Dourish, 1991; Saudou et al., 1994; Cases et al.,
1995; Heath and Hen, 1995; Artigas et al., 1996; Bj0rkum and Ursin, 1996; Crabbe
et al., 1996; Ohno and Watanabe, 1996; Yeh et al., 1996). Disruptions in serotonergic
systems have been implicated in the etiology of mental disorders such as schizophre-
nia, migraine, depression, infantile autism, eating disorders, and obsessive compul-
sive disorder (Lopez-Ibor, 1988; Tecott et al., 1995). Serotonin exerts its diverse
actions by binding to distinct cell surface receptors which have been classified into
many groups (Peroutka, 1993; Saudou and Hen, 1994). Serotonin receptors are
members of a superfamily of receptors (Strader et al., 1995) that couple to GTP-
binding regulatory proteins (G-proteins).
Based on pharmacological and molecular biological techniques, a large, growing
family of distinct serotonin receptor subtypes has been identified (Peroutka, 1988;
Boess and Martin, 1994; Saudou and Hen, 1994). The unusually large number of
receptor subtypes allows serotonin to have diverse effects in the nervous system
(Saudou and Hen, 1994). Interestingly, the heterogeneity in serotonin receptors is
much more than that found in other biogenic amine receptors. One of the reasons
suggested for this discrepancy is that the "primordial" serotonin receptor appears
to have existed prior to the evolution of muscarinic, dopaminergic, and adrenergic
receptor systems (Peroutka and Howell, 1994). The fact that the early serotonin
receptor evolved prior to other G-protein-coupled biogenic amine receptors could
account for the large number of serotonin receptors existing today (Peroutka, 1994).
The heterogeneity of serotonin receptors was first demonstrated based on
a pharmacological analysis of binding of radiolabeled serotonin, D-lysergic acid
diethylamide (LSD), and spiperone to cortical membrane fragments (Peroutka and
Snyder, 1979). Serotonin was found to bind to two distinct sites with a thousandfold
difference in affinity. The sites that bind serotonin in the nanomolar range was
designated the 5-HT, sites, and the sites that bind serotonin at the micromolar
range, but bind spiperone at the nanomolar range, were termed the 5-HT2 sites.
The hallucinogenic drug LSD binds to both sites with a high affinity. In general,
the 5-HTi type is characterized by a higher affinity for agonists than for antagonists.
Thus, the concept of multiple serotonin receptors was introduced. Further, heteroge-
neity of 5-HT| sites was demonstrated by the ability of spiperone to compete, at
low concentrations, with serotonin for some 5-HT, sites (Pedigo et al., 1981). A
subpopulation of 5-HT, sites, that has a high affinity for spiperone and serotonin,
was designated the 5HT,A sites.
Among the various types of serotonin receptors, the G-protein-coupled 5-HT,A
receptor subtype has been the most extensively studied. The reasons for this include
(i) the availability of a highly selective ligand [(±)-8-hydroxy-2-(di-yV-propylamino)
tetralin (OH-DPAT)] that allows extensive biochemical, physiological, and pharma-
cological characterization of the receptor (Gozlan et al., 1983; Middlemiss and
Fozard, 1983) and (ii) the observation that certain 5-HT,A agonists exert anxiolytic
and antidepressant effects (Blier et al., 1990). As a result, the 5-HT!A receptors
have become an important target in the development of therapeutic agents to treat
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neuropsychiatric disorders such as anxiety and depression. Besides, the 5-HT!A
receptors are implicated in regulation of blood pressure, feeding, temperature regu-
lation (Dourish et al, 1987), and regulation of working memory (Ohno and Wata-
nabe, 1996); (iii) it was the first among all the serotonin receptors to be cloned and
sequenced (Kobilka et al., 1987; Fargin et al., 1988; Albert et al., 1990). The human,
rat, and mouse 5-HT1A receptors have been cloned, and their amino acid sequences
deduced (Fargin et al., 1988; Albert et al., 1990; Charest et al, 1993). The cloning
of the 5-HTiA receptor gene has shown that it belongs to the superfamily of G-
protein-coupled receptors, with 50% amino acid homology with the /32-adrenergic
receptor in the transmembrane domain. Furthermore, the receptor has been stably
expressed in a number of neural and nonneural cell lines (Banerjee et al., 1993);
and (iv) it was the first serotonin receptor for which polyclonal antibodies were
obtained (Fargin et al., 1988; El Mestikawy et al., 1990), allowing their visualization
at the subcellular level in various regions of the brain. The 5-HT)A receptor gene
has also been recently implicated in Tourette's syndrome, a common hereditary
motor and vocal tic disorder (Lam et al., 1996).
Metal ion modulation of agonist binding is a characteristic feature of G-protein-
coupled seven transmembrane domain receptors. Thus, effects of metal ions on
agonist binding have been reported for the adrenergic receptors (Tsai and Lefko-
witz, 1978; Ernsberger and U'Prichard, 1987; Ceresa and Limbird, 1994), opiate
receptors (Pasternak et al., 1975; Lee et al., 1977; Blume, 1978; Sadee et al., 1982;
Werling et al., 1985, 1986; Yabaluri and Medzihradsky, 1997), dopamine receptors
(Creese et al, 1978; Sibley and Creese, 1983), tachykinin receptors (Morishima
et al., 1989), muscarinic acetylcholine receptor (Shiozaki and Haga, 1992), and the
bradykinin B2 receptor (Quitterer et al, 1996).
The 5-HT|A receptor is negatively coupled to the adenylate cyclase system
through G-proteins (Emerit et al, 1990; Cornfield and Nelson, 1991). Since most
seven transmembrane domain receptors are coupled to G-proteins (Clapham, 1996),
guanine nucleotides are known to regulate agonist binding. Guanine nucleotides
interact with many hormone and neurotransmitter receptor systems. For example,
GTP is necessary for the activation of neurotransmitter-sensitive adenylate cyclase
systems (Limbird, 1981). Guanine nucleotide sensitivity to agonist binding has been
shown for adrenergic receptors (U'Prichard and Snyder, 1978; Ernsberger and
U'Prichard, 1987), opiate receptors (Blume, 1978; Childers and Snyder, 1980),
dopamine receptors (Creese et al, 1978), tachykinin receptors (Morishima et al,
1989), and muscarinic acetylcholine receptor (Shiozaki and Haga, 1992).
We have recently partially purified the 5-HT,A receptor from bovine brain
hippocampus and solubilized it in an active form using a premicellar concentration
of the zwitterionic detergent CHAPS {3-[(3-cholamidopropyl)-dimethylammonio]-
1-propanesulfonate} under high-salt conditions (Chattopadhyay and Harikumar,
1996). From studies of regional distribution of the 5-HT]A receptor in the brain, it
is known that the hippocampus has a higher density of 5-HT|A receptor sites,
particularly in the dentate gyrus and CA, regions (Marcinkiewicz et al, 1984; Kia
et al, 1996). In this paper, we have examined the modulation of agonist ([3H]OH-
DPAT) binding to 5-HT!A receptors in bovine hippocampal membranes by monova-
lent and divalent cations. In addition, since the 5-HT1A receptor is coupled to G-
538 Harikumar and Chattopadhyay
proteins, we have investigated the guanine nucleotide sensitivity of the agonist
binding to the receptor in the presence and absence of metal ions. To gain further
insight into the mechanisms of agonist binding to bovine hippocampal 5-HT!A
receptors under these conditions, we have analyzed the binding affinities and binding
sites by Scatchard analysis of saturation binding data in all cases,
MATERIALS AND METHODS
Materials. Serotonin, iodoacetamide, polyethylenimine, sucrose, pargyline,
sodium azide, Tris, EDTA, EGTA, NaCl, KC1, LiCl, CaCl2, MgCl2, MnCl2, and
phenylmethylsulfonyl fluoride (PMSF) were obtained from Sigma Chemical Co. (St.
Louis, MO). Guanosine-5'-O-(3-thiotriphosphate) (GTP-y-S) was from Boehringer
Mannheim (Germany). [3H]OH-DPAT (147.2 Ci/mmol) was obtained from DuPont
New England Nuclear (Boston, MA). GF/B glass microfiber filters were from
Whatman International (Kent, U.K.). A bicinchoninic acid (BCA) reagent kit for
protein estimation was obtained from Pierce (Rockford, IL). Fresh bovine brains
were obtained from a local slaughterhouse within 10 min of death and the hippocam-
pal region was carefully dissected out. The hippocampi were immediately flash-
frozen in liquid nitrogen and stored at -70°C till further use.
Preparation of Crude Hippocampal Membranes. Bovine hippocampal tissue
(~120 g) was homogenized as 10% (wt/vol) in a polytron homogenizer in buffer
A (2.5 mM Tris, 0.32 M sucrose, 5 mM EDTA, 5 mM EGTA, 0.02% sodium azide,
0.24 mM PMSF, 10 mM iodoacetamide, pH 7.4). The homogenate was centrifuged
at 900g for 10 min at 4°C. The supernatant was filtered through four layers of
cheesecloth and the pellet was discarded. The supernatant was further centrifuged
at 50,000g for 20 min at 4°C. The resulting pellet was suspended in 10 vol of buffer
B (50 mM Tris, 1 mM EDTA, 0.24 mM PMSF, 10 mM iodoacetamide, pH 7.4)
using a Dounce homogenizer and centrifuged at 50,000g for 20 min at 4°C. This
procedure was repeated till the supernatant was clear. The final pellet (crude mem-
brane) was resuspended in a minimum volume of 50 mM Tris buffer (pH 7.4),
homogenized using a Dounce homogenizer, flash-frozen in liquid nitrogen, and
stored at -70°C. The homogenate thus obtained was either used directly for receptor
binding or incubated with various concentrations of monovalent (Na+, K+, Li+) or
divalent cations (Ca2+, Mn2+, Mg2+) in the presence and absence of GTP-y-S, a
nonhydrolyzable analogue of GTP, before radioligand binding assay was performed.
Receptor Binding Assay. Tubes in triplicate containing 1-1.2 mg of total
protein in a total volume of 1 ml of buffer C (50 mM Tris, 2 mM MgCl2, 20 /^M
pargyline, 0.1% ascorbic acid, pH 7.4; it should be noted that MgCl2 was not used
in experiments where Mg2+ effects on agonist binding were examined) were incu-
bated with 0.29 nM [3H]OH-DPAT (sp. act. 147.2 Ci/mmol) for 1 hr at room
temperature in the presence and absence of 10 /iM unlabeled 5-HT. The incubation
was terminated by rapid filtration under vacuum in a Millipore multiport filtration
apparatus through Whatman GF/B (1.0-/Am pore size) 2.5-cm-diameter glass mi-
crofiber filters, which were presoaked in 0.3% polyethylenimine for 3 hr (Bruns
etal, 1983). The filters were then washed three times with 3 ml of ice-cold water
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Table I. Affinity and £„,,„ Values of [3H]OH-DPAT Binding of
5-HT,A Receptor from Bovine Hippocampal Membranes"
Metal ion
None (native membrane)
Na'
K*
Li h
Ca21
Mg2f
Mn2 '
K,
(nM)
1.91 ± 0.06
(2.11 ± 0.56)"
3.42 ±0.18
(2.10 ± 0.64)*
1.51 ± 0.43
3.72 ± 0.30
(2.45 ± ().52)b
1.21 ± 0.05
1.38 ± 0.33
(2.54 ± 0.67)''
1.02 ± 0.10
B,,,,«
(fmol/mg protein)
120.01 27.70
(34.57 3.63)"
71.60 14.39
(14.65 0.76)"
82.93 5.11
86.59 ± 23.31
(31.81 ± 5.97)"
94.21 ± 0.62
83.63 ± 11.58
(32.94 ± 2.99)"
91.16 ± 9.34
" The binding parameters shown in this table represent the mean ± standard
deviation of duplicate points from three independent experiments, while
saturation binding data shown in Figs. 2, 4, and 6 are from representative
experiments. See Materials and Methods for other details.
* In the presence of 50 pM GTP-y-S.
and dried, and the retained radioactivity was measured in a Packard Tri-Carb 1500
scintillation counter using 5 ml of scintillation fluid.
Saturation Binding Assay. Saturation binding assays were carried out using
different concentrations of radiolabeled ligand (sp. act. 147.2 Ci/mmol) with varying
concentrations of [3H]OH-DPAT (0.1-7.5 nM) using 1.2 mg of crude membrane.
Nonspecific binding was measured in the presence of 10 /j.M unlabeled 5-HT.
Binding assays were carried out at room temperature as mentioned above (see
receptor binding assay) in the presence of different metal ions at a specific concentra-
tion. The specific metal ion concentration at which the assay was done was the half-
maximal inhibition concentration (IC50 value) for monovalent cations, determined
using the LIGAND program (McPherson, 1985), obtained from Biosoft, Cambridge,
U.K. For divalent cations, the concentrations at which maximum stimulation in
binding were observed were used for saturation binding assays. Binding data were
analyzed as described by Hulme (1990). The concentration of bound ligand was
calculated from the equation
RL* = 10~9 x BI(V X SA X 2220)M
where B is the bound radioactivity in dpm (i.e., total dpm - nonspecific dpm), V
is the assay volume in ml, and S A is the specific activity of the radioligand. Scatchard
plots (i.e., plots of RL*/L* vs L*) were analyzed using Sigma-Plot (Version 3.1)
in an IBM PC. The dissociation constants (Kd) were obtained from the negative
inverse of the slopes, determined by linear regression analysis of the plots (r =
0.93-0.99). The Bmax values were obtained from the intercept on the abscissa. The
Bmax values reported in Table I have been normalized with respect to the amount
of crude membrane used. The binding parameters shown in Table I were obtained
by averaging the results of three independent experiments, while saturation binding
data shown in Figs. 2, 4, and 6 are from representative experiments. The extent of
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Fig. 1. Effect of increasing concentrations of GTP-y-S on the
specific binding of ['H|OH-DI'AT to the 5-HT,A receptor from
bovine hippocampal membranes. Values are expressed as a percent-
age of the specific binding obtained in the absence of GTP-y-S.
The data points are the means of duplicate points from three inde-
pendent experiments. See Materials and Methods for other details.
G-protein coupling was monitored by saturation binding assays done with and
without 50 ju,M GTP-y-S. Protein concentration was determined using BCA reagent
(Smith et al, 1985).
RESULTS
Ligand binding assay using the 5-HT!A agonist [3HJOH-DPAT shows the pres-
ence of high-affinity binding sites in bovine hippocampal membranes with apparent
dissociation constant of 1.91 nM obtained from saturation binding studies (see
Table I). We found the ligand binding to be optimal with 1.2 mg of the crude
membrane. The crude membrane prepared from bovine hippocampus typically
showed a 10- to 12-fold enrichment in the receptor content as found by receptor
binding assay (data not shown).
Figure 1 shows the inhibition of OH-DPAT binding to the 5-HT,A receptor
by GTP-y-S, a nonhydrolyzable analogue of GTP, in a characteristic concentration-
dependent manner. This shows that the 5-HT]A receptor in these membranes is
coupled to G-proteins, as suggested by previous reports for 5-HT,A receptors from
other sources (Schlegel and Peroutka, 1986; Emerit et al, 1990; Cornfield and
Nelson, 1991; Harrington and Peroutka, 1990). In fact, OH-DPAT has previously
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Fig. 2. Scatchard analysis of the specific binding of ['HjOH-DPAT to the 5-
HT|A receptor from bovine hippocampal membranes in the presence (O) and
absence (•) of 50 pM GTP-y-S. The concentration of ['H]OH-DPAT ranged
from 0.1 to 7.5 nAf. Data shown are from a representative experiment and each
point is the mean of duplicate determinations. See Materials and Methods for
other details.
been shown to bind to the high-affinity binding sites of only that population of
5-HT|A receptors that is G-protein coupled (Newman-Tancredi et al, 1992; Sund-
aram et al, 1993, 1995).
Figure 2 shows the Scatchard analysis of the specific binding of [3H]OH-DPAT
to the high-affinity 5-HT,A receptor in bovine hippocampal membranes. Analysis
of the Scatchard plot shows tight binding (Kd = 1.91 nM) with a maximum number
of binding sites (Bmx) of about 120 fmol/mg protein (see Table I). Table I shows
that in the presence of GTP-y-S, both the binding affinity and the number of binding
sites are reduced. Thus, while the binding affinity is reduced, corresponding to a
/Kd of 2.77 nM, the number of binding sites is reduced by 71%. GTP-y-S appears
to induce a transition of the 5-HT)A receptor from the high-affinity to a low-affinity
state (Schlegel and Peroutka, 1986). Such affinity transition induced by guanine
nucleotides has been observed previously for the adrenergic receptors (Hoffman
and Lefkowitz, 1980).
Figure 3 shows the inhibition of [3H]OH-DPAT binding to 5-HT,A receptors
by monovalent cations such as Na+, K+, and Li4". There is a concentration-dependent
inhibition of binding in all cases, with the potency decreasing in the order Li+ >
K+ > Na+. Figure 3 also shows that the agonist binding is further inhibited in the
presence of GTP-y-S in all cases, implying that the receptor is coupled to G-proteins.
Closer inspection of Figs. 1 and 3 show that the inhibition to agonist binding by
monovalent ions and GTP-y-S is additive to a large extent. Such additive inhibition
by guanine nucleotide and monovalent ions was previously observed in the case of
opiate receptors (Childers and Snyder, 1980).
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Fig. 3. Effect of monovalent cations on ['H]OH-DPAT specific binding to the 5-HT,A receptor from
bovine hippocampal membranes in the presence (O) and absence (•) of 50 /j.M GTP-y-S. The data
points are the means of duplicate points from three independent experiments. See Materials and Methods
for other details.
Scatchard analysis of the saturation binding assay (Fig. 4) shows that in the
case of Na+ and Li+, there is a reduction in the specific binding affinity (Kd = 3.42
and 3.72 nM, in the case of Na+ and Li+, respectively) of the agonist (see Table I).
This is accompanied by a concomitant decrease in the number of binding sites.
There is a 40% decrease in the number of binding sites in presence of Na+ ions,
while the decrease in binding sites is about 28% for Li+ (Table I). However, these
results are somewhat different in the case of K+ ions. There is an increase in binding
affinity (corresponding to a /Cd of 1.51 nM) with an accompanying 31% reduction
in the number of binding sites (Table I). The interaction of monovalent cations
with 5-HTiA receptors is thus characterized by an altered agonist binding affinity
and a reduction in number of binding sites.
Table I also shows that when GTP-y-S is present along with monovalent cations
such as Na+ and Li+, there is a further reduction in agonist binding sites. Thus,
there is a 88% decrease in binding sites when GTP-y-S is present along with Na+
(compared to native membranes). The corresponding figure for Li+, when present
with GTP-y-S, is 73%. The agonist binding affinity (KA = 2.10 and 2.45 nM for Na+
and Li+, respectively), on the other hand, is slightly lowered compared to that of
the native membrane (Kd = 1.91 nM).
Figure 5 shows the modulation of [3H]OH-DPAT binding to 5-HT,A receptors
by divalent cations such as Ca2+, Mg2+, and Mn2+. The effect of divalent cations on
agonist binding appears to be more complex. There is a concentration-dependent
enhancement in binding up to a certain concentration in all cases. The concentration
at which maximum enhancement of binding is observed is specific to the metal ion
used. Thus, while agonist binding is maximally enhanced in the presence of 10 mM
Ca2+ or Mg2+, the corresponding concentration for Mn2+ is 1 mM. The sensitivity
of divalent cations for stimulating agonist binding therefore decreases in the order
Mn2+ > Ca2+ « Mg2+. At higher concentrations of divalent cations, inhibition to
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Fig. 4. Scatchard analysis of the specific binding of
['H]OH-DPAT to the 5-HT,A receptor from bovine
hippocampal membranes in the presence of monova-
lent cations with (O) and without (•) 50 ^ M GTP-
7-S. The concentration of [3H]OH-DPAT ranged
from 0.1 to 7.5 nM. The concentrations of monova-
lent cations used were their respective IC5|> values
(Na*, 33.00 mM; Li*, 5.53 mM; K*. 31.00 mM). Data
shown are from a representative experiment and
each point is the mean of duplicate determinations.
See Materials and Methods for other details.
agonist binding is observed similar to results obtained with monovalent cations.
These results are in agreement with previous reports in which divalent cations have
been shown to enhance agonist binding in 5-HT receptors (Hall et al, 1986), opiate
receptors (Pasternak et al, 1975; Sadee et al, 1982), and dopamine receptors (Creese
et al, 1978). Figure 5 also shows that the agonist binding is further inhibited in the
presence of GTP-y-S in all cases, implying that the receptor is coupled to G-proteins.
Interestingly, the enhancement of agonist binding up to a certain concentration
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Fig. S. Effect of divalent cations on ['H]OH-DPAT
specific binding to the 5-HT,A receptor from bovine
hippocampal membranes in the presence (O) and ab-
sence (•) of 50 pM GTP--y-S. The data points are
the means of duplicate points from three independent
experiments. See Materials and Methods for other de-
tails.
observed when divalent cations are present alone (discussed above) is masked in
the presence of GTP-y-S for Ca2+ and Mn2+. In the case of Mg2+, the enhancement
in binding is still observed in the presence of GTP-y-S, although the concentration
at which maximum binding takes place is about two orders of magnitude lower (0.1
mM) than observed in the absence of GTP-y-S (Figure 5). This could be due to
the specific effects of Mg2+ on the interaction of G-proteins with GTP-y-S (Higashi-
jima et al, 1987).
Figure 6 shows the Scatchard analysis of the saturation binding assay in the
presence of divalent cations. There is an increase in binding affinity of the agonist
in all cases (see Table I). The apparent dissociation constants (/Q in the presence
of Ca2+, Mg2+, and Mn2+ are 1.21,1.38, and 1.02 nA/, respectively. This is accompanied
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Fig. 6. Scatchard analysis of specific ['H]OH-DPAT
binding to the 5-HT|A receptor from bovine hippocam-
pal membranes in the presence of divalent cations with
(O) and without (•) 50 ^ M GTP-y-S. The concentra-
tion of f'HJOH-DPAT ranged from 0.1 to 7.5 nM. The
concentrations of divalent cations used were 10 mM
in the case of Ca2+ and Mg2t and 1 mM for Mn2+. Data
shown are from a representative experiment and each
point is the mean of duplicate determinations. See
Materials and Methods for other details.
by a concomitant decrease in the number of binding sites. The reduction in binding
sites is 22, 30, and 24% in the presence of Ca2+, Mg2+, and Mn2t, respectively
(see Table I). The interaction of divalent cations with 5-HT,A receptors then is
characterized by an increase in agonist binding affinity and a reduction in number
of binding sites.
It is interesting to note from Table I that the presence of GTP-y-S along with
Mg2+ lowers the agonist binding affinity corresponding to a K^ of 2.54 nM. This
represents a significantly lower binding affinity compared to that with Mg2+ alone
(Ka = 1.38 nM) as well as compared to that of the control membranes (Kd = 1.91
nM). Such affinity transitions of G-protein-coupled seven transmembrane domain
receptors induced by divalent cations have been reported previously (Sadee et al.,
1982; DeVinney and Wang, 1995). This is accompanied by a 73% decrease in binding
sites when GTP-y-S is present along with Mg2+ (compared to native membranes).
DISCUSSION
There is heterogeneity of the [3H]OH-DPAT binding sites in different regions
of the brain. Low-affinity binding sites are present in the striatum and cerebral
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cortex, while the CA, and dentate gyrus regions of the hippocampus show high-
affinity binding sites (Nenonene et al, 1994; Gozlan et al., 1995). The hippocampal
5-HT,A receptors are localized postsynaptically (Verge et al., 1986; Palacios et al.,
1990). These are the sites that are apparently labeled by [3H]OH-DPAT (Hall et al.,
1986; Dumuis et al., 1988). Using the 5-HTIA agonist ['HJOH-DPAT, we show here
that high-affinity agonist binding sites are present in bovine hippocampus and are
coupled to G-proteins. The modulation of agonist binding to 5-HT|A receptors from
bovine hippocampus by metal ions and guanine nucleotide is the focus of this
report. Metal ion modulation and guanine nucleotide sensitivity of agonist binding
are important characteristics of G-protein-coupled receptors. In this manuscript,
we show that these characteristics are exhibited by the 5-HT,A receptor from bovine
hippocampus. Although metal ion modulation and guanine nucleotide sensitivity
of agonist binding for other serotonin receptors have been reported previously
(Battaglia et al., 1984; Hall et al., 1986), the present results are the first detailed
report describing these effects for the 5-HT!A subtype receptor, especially from
bovine hippocampus. In addition, in most earlier reports the accompanying changes
in binding affinities and binding sites have not been characterized. We have analyzed
the changes in binding affinities and binding sites under these conditions by Scatch-
ard analysis of saturation binding data.
Our results show that GTP--y-S, a nonhydrolyzable GTP analogue, induces
transition of the bovine hippocampal 5-HT!A receptor from the high-affinity to a
low-affinity state (Schlegel and Peroutka, 1986). The latter state of the receptor is
sometimes referred to as the "nonbinding state" (Harrington and Peroutka, 1990).
The affinity transition is accompanied by a decrease in the number of binding sites.
These observations can be rationalized in terms of the "ternary complex model"
(De Lean et al., 1980; Wregget and De Lean, 1984), which assumes that the agonist
affinity for its binding site and the fraction of total receptors in any given conforma-
tion will depend on the extent of receptor-G-protein coupling. The G-protein-
coupled form of the receptor will exhibit a high-affinity agonist state, whereas the
uncoupled receptor will display a lower affinity for the agonist. Receptor isomeriza-
tion between high- and low-affinity states can be reversibly shifted by guanyl
nucleotides. Similar findings have been reported previously by other groups
(Schlegel and Peroutka, 1986; Harrington and Peroutka, 1990; Emerit et al., 1990,
1991; Khawaja et al., 1995).
Rhodopsin and the /3-adrenergic receptor serve as representative members for
the study of the structure and function of the G-protein-coupled receptor family
(Strosberg, 1991; Donnelly and Findlay, 1994; Strader et al., 1995). The alighnment
of G-protein-coupled receptor sequences indicates that the hydrophilic components
of the transmembrane segments are the most likely site of agonist-receptor interac-
tions. It is known that the agonist binding site for the 0-adrenergic receptor is in
the membrane-embedded region of the receptor, similar to the retinal binding site
in rhodopsin (Dixon et al., 1987; Strader et al., 1987). Subsequent studies using the
/3-adrenergic, a-adrenergic, and muscaranic receptors have demonstrated that the
location of the binding site inside the membrane is a common feature of all these
receptors (Ostroski et al., 1992). The agonists for these receptors contain an amine
group that is believed to form a complex with the negatively charged aspartatc
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residue in the third transmembrane domain. This is believed to constitute one of
the epitopes necessary for high-affinity binding. The primary structures of the
members of the G-protein-coupled receptor family indicate that this binding mecha-
nism is conserved in all the receptors that have a charged amine group as a feature
of their activating ligand. All cloned 5-HT receptors also contain the aspartic acid
residue in the third transmembrane domain at a comparable position (Wang
et al, 1993).
For serotonin receptors, mutagenesis and molecular modeling studies have
shown that the ligand binding site is located in a transmembrane domain (Ho et al.,
1992; Chanda et al., 1993; Peroutka, 1993; Wang et al., 1993; Sylte et al., 1993, 1996;
Bremner et al., 1997). In the case of 5-HTIA receptors, molecular dynamics (Sylte
et al., 1996) and site-specific and random mutagenesis studies (Ho et al., 1992;
Chanda et al, 1993) have provided vital insights into receptor structure and function.
The 5-HT|A receptor agonists belong to diverse chemical classes but have in common
a basic amino group and an aromatic ring that usually carries groups such as an
hydroxyl or a methoxy which has the potential for hydrogen bond formation (Ho
et al., 1992). The involvement of the conserved residues Asp82, Asp"6, Ser19'', and
Thr200 for agonist binding to the 5-HTIA receptor has been pointed out by site-
directed mutation (Ho et al., 1992) as well as molecular modeling studies (Sylte
et al., 1996). Monovalent cations such as Na+ and Li+ could induce conformational
change of the agonist binding site in such a way as to alter the binding affinity and
sites. Interestingly, a conserved aspartate residue in the second transmembrane
helix of many G-protein-coupled receptors has been implicated in agonist binding
and modulation by sodium ions (Horstman et al., 1990). Thus, in the case of the
a2-adrenergic receptor, Asp7'' has been shown to be directly involved in regulation
of the interaction of Na+ with the receptor (Horstman et al., 1990; Kong et al.,
1993). This is achieved by binding of Na" to the carboxylate form of the residue.
A conserved aspartate (Asp82) in a similar region of the 5-HT1A receptor has been
shown to be essential for agonist binding (Ho et al., 1992). The monovalent ions
could interact with Asp*2 of the 5-HT|A receptor, thereby altering the agonist binding
site and affinity.
The 5-HT1A receptors are known to exist in different conformational states
with varying affinities (Mongeau et al., 1992). It has been proposed that the G-
protein-coupled seven transmembrane domain receptors are in equilibrium between
the inactive conformation (R) and a spontaneously active conformation (R*) that
can couple to G-proteins in the absence of ligand (Bond et al., 1995). Agonists such
as OH-DPAT have a high affinity for the active-state receptor (R*) and thus
increase the concentration of R*. The inactive state (R) is not coupled to G-proteins
and is favored in the presence of monovalent cations such as Na+ and Li+. In the
presence of GTP--y-S, the equilibrium is shifted further toward the inactive state.
The agonist-dependent alteration of the balance between receptor activation and
inactivation serves as the basis of receptor function. Disregulation of the balance
results in constitutive receptor activity leading to various diseases (Lefkowitz, 1993).
Lithium as a salt is used in the treatment of mania, in the augmentation
treatment of depression, and in the prophylaxis of manic-depressive illness (Bel-
maker et al., 1996). It has been proposed that the 5-HT!A receptors could be the
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site of action of antidepressants (Nenonene et al., 1994). It is known that Li+ affects
the enhanced binding of GTP to G-proteins caused by neurotransmitter stimulation
of receptors (Belmakeret al., 1996). Short-term lithium treatment has been reported
to enhance responsiveness of postsynaptic but not of presynaptic 5-HT,A receptors
(Blier et al, 1987). Our results show that Li+ can induce affinity transition in bovine
hippocampal 5-HT,A receptors, which are located postsynaptically (Verge et al.,
1986; Palacios et al., 1990), resulting in low-affinity receptors with an accompanying
reduction in number of binding sites.
Our results show that divalent cations have a complex effect on the binding
of [3H]OH-DPAT to the 5-HT1A receptor. Divalent cations showed enhancement
of binding at a certain concentration in all cases, with an accompanying increase
in binding affinity. It is known that divalent cations are required for the stabilization
of an agonist-specific high-affinity state at the expense of the low-affinity state by
promoting the formation of 5-HTiA receptor-ligand-G-protein ternary complexes
(Khawaja et al, 1995).
The interactions of receptors with G-proteins are known to be regulated by
Mg2t (Higashijima et al., 1987). The 5-HTu receptor is negatively coupled to the
adenylate cyclase system through pertussis toxin-sensitive Grprotein (Harrington
et al., 1988; Cornfield and Nelson, 1991). Mg2+ has the ability to interact with GTP-
•y-S (Higashijima et al, 1987) to form a complex along with G-protein (Ga-GTP-
-y-S • Mg2+). This complex, upon interaction with the receptor, could induce the
high-affinity state of the receptor (Shiozaki and Haga, 1992).
In summary, our results show that the interaction of monovalent cations with
5-HTi A receptors is characterized by a concentration-dependent inhibition of agonist
binding, an altered agonist binding affinity, and a reduction in the number of binding
sites. Divalent cations display more complex behavior. There is an enhancement
of agonist binding up to a certain concentration, followed by inhibition in agonist
binding at higher concentrations. This is accompanied by an increase in binding
affinity with a concomitant reduction in binding sites. The effect of the metal ions on
agonist binding is strongly modulated in the presence of GTP-y-S, a nonhydrolyzable
analogue of GTP, indicating that these receptors are coupled to G-proteins. The
5-HTiA receptor activity in bovine hippocampus is therefore very well regulated by
the ionic condition of the environment. Multiple-affinity states of the 5-HT,A recep-
tor induced by metal ions and guanine nucleotides could be physiologically signifi-
cant. For example, the effect of Na+ on 5-HT,A receptor affinity states may be
relevant in hypertension since excess dietary Na+ may exert its pressor effect in
part by potentiating 5-HT,A receptor function (Insel and Motulsky, 1984). In view
of the multiple roles played by the serotonergic systems in the central and peripheral
nervous systems, the results presented here could be significant in the overall
regulation of receptor activity for G-protein-coupled seven-transmembrane do-
main receptors.
ACKNOWLEDGMENTS
This work was supported by a grant (BT/R&D/9/5/93) from the Department
of Biotechnology, Government of India, to A.C. K.G.H. thanks the Department
Modulation of 5-HT,A Agonist Binding 549
of Biotechnology for the award of a postdoctoral fellowship. Some of the preliminary
experiments were done by one of us (A.C.) as a Wood-Whelan Fellow (offered by
the International Union of Biochemistry and Molecular Biology) at the University of
California, Santa Cruz. We thank Drs. S. Harinarayana Rao and S. Rajanna for
help with the tissue collection and Drs. Howard H. Wang and Rebekah DeVinney
for help and useful discussions during the initial stage of this work.
REFERENCES
Albert, P. R., Zhou, Q.-Y., Van Tol, H. H. M., Bunzow, J. R., and Civelli, O. (1990). Cloning, functional
expression, and mRNA tissue distribution of the rat 5-hydroxytryptamine,A receptor gene. J. Biol.
Chem. 265:5825-5832.
Arligas, F., Romero, L., De Montigny, C., and Blier, P. (1996). Acceleration of the effect of selected
antidepressant drugs in major depression by 5-HT]A antagonists. Trends Neurosci. 19:378-383.
Banerjee, P., Berry-Kravis, E., Bonafede-Chhabra, D., and Dawson, G. (1993). Heterologous expression
of the serotonin 5-HT!A receptor in neural and non-neural cell lines. Biochem. Biophys. Res.
Commun. 192:104-110.
Battaglia, G., Shannon, M., and Titeler, M. (1984). Guanyl nucleotide and divalent cation regulation
of cortical S2 serotonin receptors. J. Neitrochem. 45:1213-1219.
Belmaker, R. H., Bersudsky, Y., Agam, G., Levine, J., and Kofman, O. (1996). How docs lithium work
on manic depression. Annu. Rev. Med. 47:47-56.
Bj0rkum, A. A., and Ursin, R. (1996). Sleep/waking effects following intrathecal administration of the
5-HT,A agonist 8-OH-DPAT alone and in combination with the putative 5-HT,A antagonist NAN-
190 in rats. Brain Res. Bull. 39:373-379.
Blier, P., De Montigny, C., and Tardif, D. (1987). Short-term lithium treatment enhances responsiveness
of postsynaptic 5-HT,A receptors without altering 5-HT autoreceptor sensitivity: an electrophysiolog-
ical study in the rat brain. Synapse 1:225-232.
Blier, P., De Montigny, C, and Chaput, Y. (1990). A role for the serotonin system in the mechanism
of action of antidepressant treatments: Preclinical evidence. / Clin. Psychiatry 51:14-20.
Blume, A. J. (1978). Interaction of ligands with the opiate receptors of brain membranes: regulation
by ions and nucleotides. Proc. Natl. Acad. Sci. USA 75:1713-1717.
Boess, F. G., and Martin, I. L. (1994). Molecular biology of 5-HT receptors. Neitropharnwcotogy
33:275-317.
Bond, R. A., Leff, P., Johnson, T. D., Milano, C. A., Rockman, H. A., McMinn, T. R., Appasundaram,
S., Hyek, M. F., Kenakin, T. P., Allen, A. F., and Lefkowitz, R. J. (1995). Physiological effects
of inverse agonists in transgenic mice with myocardial overexpression of the /32-adrenoceptor.
Nature 374:272-276.
Bremner, D. H., Ringan, N. S., and Wishart, G. (1997). Modeling of the agonist binding site of serotonin
human 5-HT,A, 5-HT,u,, and 5-HT,D/1 receptors. Eur. J. Med. Chem. 32:59-69.
Bruns, R. F., Lawson-Wendling, K., and Pugsley, T. A. (1983). A rapid filtration assay for soluble
receptors using polyethylenimine-treated filters. Anal. Biochem. 132:74-81.
Cases, O., Seif, I., Grimsby, J., Gaspar, P., Chen, K., Pournin, S., Muller, U., Aguet, M., Babinet, C.,
Shih, J. C,, and De Maeyer, E. (1995). Aggressive behavior and altered amounts of brain serotonin
and nonrepinephrine in mice lacking MAOA. Science 268:1763-1766.
Ceresa, B. P., and Limbird, L. E. (1994). Mutation of an aspartate residue highly conserved among
G-protein-coupled receptors results in nonreciprocal disruption of <*2-adrenergic receptor-G-protein
interactions. J. Biol. Chem. 269:29557-29564.
Chanda, P. K., Minchin, M. C. W., Davis, A. R., Greenberg, L., Reilly, Y., McGregor, W. H., Bhat, R.,
Lubeck, M. D., Mizutani, S., and Hung, P. P. (1993). Identification of residues important for ligand
binding to the human 5-hydroxytryptamine,A serotonin receptor. Mol. Pharmacol. 43:516-520.
Charest, A., Wainer, B. H., and Albert, P. R. (1993). Cloning and differentiation-induced expression
of a murine serotonin,A receptor in a septal cell line. /. Neurosci. 13:5164-5171.
Chattopadhyay, A., and Harikumar, K. G. (1996). Dependence of critical micelle concentration of a
zwitterionic detergent on ionic strength: implications in receptor solubilization. FEBS Lett.
391:199-202.
Chattopadhyay, A., Rukmini, R., and Mukherjee, S. (1996). Photophysics of a neurotransmitter: loniza-
tion and spectroscopic properties of serotonin. Biophys. J. 71:1952-1960.
550 Harikumar and Chattopadhyay
Childers, S. R., and Snyder, S. H. (1980). Differential regulation by guanine nucleotidcs of opiate agonist
and antagonist receptor interactions. / Neitrochem. 34:583-593.
Chojnacka-Wojcik, E., Tatarczynska, E., Golembiowska, K., and Pr/.egalinski, E. (1991). Involvement
of 5-HT,A receptors in the antidepressant-like activity of gepirone in the forced swimming test in
rats. Neumpharmacotogy 30:711-717.
Clapham, D. E. (1996). The G-protein nanomachine. Nature 379:297-299.
Cornfield, L. J., and Nelson, D. L. (1991). Biochemistry of 5-hydroxytryptamine receptor subtypes:
Coupling to second messenger systems. In Peroutka, S. J. (ed.), Serotonin Receptor Subtypes: Basic
and Clinical Aspects, Wiley-Liss, New York, pp. 81-102.
Crabbe, J. C., Phillips, T. J., Feller, D. J., Hen, R., Wenger, C. D., Lessov, C. N., and Schafer, G. L.
(1996). Elevated alcohol consumption in null mutant mice lacking 5-HT,n serotonin receptors.
Nature Genet. 14:98-101.
Creese, I., Prosser, T., and Snyder, S. H. (1978). Dopamine receptor binding: Specificity, localization
and regulation by ions and guanyl nucleotides. Life Sci. 23:495-500.
De Lean, A., Stadel, J. M., and Lefkowitz, R. J. (1980). A ternary complex model explains the agonist-
specific binding properties of the adenylate cyclasc-coupled to /3-adrenergic receptor. J. Biol.
Chem. 255:7108-7117.
DeVinney, R., and Wang, H. H. (1995). Mg2* enhances high affinity [ 'H |-8-hydroxy-2-(di-N-propylamino)
tetralin binding and guanine nucleotide modulation of serotonin-la receptors. /. Receptor Signal
Transducl. Res. 15:757-771.
Dixon, R. A. F., Sigal, I. S., Candelore, M. R., Register, R. B., Scattergood, W., Rands, E., and Strader,
C. D. (1987). Structural features required for Hgand binding to the 0-adrenergic receptor. EMBO
J. 6:3269-3275.
Donnelly, D., and Findlay, J. B. C. (1994). Seven-helix receptors: Structure and modelling. Curr. Opin.
Sir. Biol. 4:582-589.
Dourish, C. T., Ahlenius, S., and Hutson, P. H. (1987). Brain 5-HT,A Receptors, Ellis Horwood, Chiches-
ter, U.K.
Dumuis, A., Sebben, M., and Bockaert, J. (1988). Pharmacology of 5-hydroxytryptamine-lA receptors
which inhibit cAMP production in hippocampal and cortical neurons in primary culture. Mot.
Pharmacol 33:178-186.
El Mestikawy, S., Riad, M., Laporte, A. M., Verge, D., Daval, G., Gozlan, H., and Hamon, M. (1990).
Production of specific anti-rat 5-HT,A receptor antibodies in rabbits injected with a synthetic peptide.
Neurosci. Lett. 118:189-192.
Emerit, M. B., El Mestikawy, S., Gozlan, H., Rouot, B., and Hamon, M. (1990). Physical evidence of
the coupling of solubilized 5-HT[A binding sites with G regulatory proteins. Biochem. Pharma-
col. 39:7-18.
Emerit, M. B., Miquel, M. C., Gozlan, H., and Hamon, M. (1991). The GTP-insensitive component of
high affinity [3H]8-hydroxy-2-(di-«-propylamino)tetralin in the rat hippocampus corresponds to an
oxidized state of the 5-hydroxytryptamineIA receptor. J. Neurochem. 56:1705-1716.
Ernsberger, P., and U'Prichard, D. C. (1987). Modulation of agonist and antagonist interactions at
kidney a,-adrenoceptors by nucleotides and metal ions. Eur. J. Pharmacol. 133:165-176.
Fargin, A., Raymond, J. R., Lohse, M. J., Kobilka, B. K., Caron, M. G., and Lefkowitz, R. J. (1988).
The genomic clone G-21 which resembles a /3-adrenergic receptor sequence encodes the 5-HT,A
receptor. Nature 335:358-360.
Gozlan, H., El Mestikawy, S., Pichat, L., Glowinski, J., and Hamon, M. (1983). Identification of presynap-
tic serotonin autoreceptors using a new ligand: 'H-PAT. Nature 305:140-142.
Gozlan, H., Thibault, S., Laporte, A.-M., Lima, L., and Hamon, M. (1995). The selective 5-HT,A antagonist
radioligand [1H]WAY 100635 labels both G-protein-coupled and free 5-HT,A receptors in rat brain
membranes. Eur. J. Pharmacol. 288:173-186.
Hall, M. D., Gozlan, H., Emerit, M. B., El Mestikawy, S., Pichat, L., and Hamon, M. (1986). Differentiation
of pre- and post-synaptic high affinity serotonin receptor binding sites using physico-chemical
parameters and modifying agents. Neurochem. Res. 11:891-912.
Harrington, M. A., and Peroutka, S. J. (1990). Modulation of 5-hydroxytryptaminC|A receptor density
by non-hydrolyzable GTP analogues. J. Neurochem. 54:294-299.
Harrington, M. A., Oksenberg, D., and Peroutka, S. J. (1988). 5-Hydroxytryptamine,A receptors are
linked to a Gradenylate cyclase complex in rat hippocampus. Eur. J. Pharmacol. 154:95-98.
Heath, M. J. S., and Hen, R. (1995). Genetic insights into serotonin function. Curr. Biol. 5:997-999.
Hen, R. (1992). Of mice and flies: Commonalities among 5-HT receptors. Trends Pharmacol. Sci.
13:160-165.
Higashijima, T., Ferguson, K. M., Sternweis, P. C., Smigel, M. D., and Gilman, A. G. (1987). Effects
Modulation of 5-HT,4 Agonist Binding 551
of Mg2* and tKe /3-y-subunit complex on the interactions of guanine nucleotides with G proteins.
J. Biol. Chem. 262:762-766.
Ho, B. Y., Karschin, A., Branchek, T., Davidson, N., and Lester, H. A. (1992). The role of conserved
aspartate and serine residues in ligand binding and in function of the 5-HT,A receptor: a site directed
mutation study. FEES Lett. 312:259-262.
Hoffman, B. B., and Lefkowitz, R. J. (1980). Radioligand binding studies of adrenergic receptors: New
insights into molecular and physiological regulation. Annu. Rev. Pharmacol. Toxicol. 20:581-608.
Horstman, D. A., Brandon, S., Wilson, A. L., Guyer, C. A., Cragoe, E. J., and Limbird, L. E. (1990).
An aspartate conserved among G-protein receptors confers allosteric regulation of a2-adrenergic
receptors by sodium. /. Biol. Chem. 265:21590-21595.
Hulme, E. C. (1990). Receptor binding studies, a brief outline. In Hulme, E. C. (ed.), Receptor-Effector
Coupling: A Practical Approach, IRL Press, New York, pp. 203-215.
Insel, P. A., and Motulsky, H. J. (1984). A hypothesis linking intracellular sodium, membrane receptors,
and hypertension. Life Sci. 34:1009-1013.
Jacobs, B. L., and Azmitia, E. C. (1992). Structure and function of the brain serotonin system. Physiol.
Rev. 72:165-229.
Khawaja, X., Evans, N., Reilly, Y., Ennis, C., and Michin, M. C. W. (1995). Characterisation of the
binding of [3H] WAY-100635, a novel 5-hydroxytryptamineiA receptor antagonist, to rat brain. J.
Neurochem. 64:2716-2726.
Kia, H. K., Miquel, M.-C., Brisorgueil, M.-J., Daval, G., Riad, M., El Mestikawy, S., Hamon, M., and
Verge, D. (1996). Immunocytochemical localization of serotonin1A receptors in the rat central
nervous system. J. Comp. Neural. 365:289-305.
Kobilka, B. K., Frielle, T., Collins, S., Yang-Feng, T., Kobilka, T. S., Francke, U., Lefkowicz, R. J., and
Caron, M. G. (1987). An intronless gene encoding a potential member of the family of receptors
coupled to guanine nucleotide regulatory proteins. Nature 329:75-79.
Kong, H., Raynor, K. Yasuda, K., Bell, G. I,, and Reisine, T. (1993). Mutation of an aspartate ar residue
89 in somatostatin receptor subtype 2 prevents Na* regulation of agonist binding but does not alter
receptor-G protein association. Mol. Pharmacol. 44:380-384.
Lam, S., Shen, Y., Nguyen, T., Messier, T. L., Brann, M., Comings, D., George, S. R., and O'Dowd,
B. F. (1996). A serotonin receptor gene (5HT1A) variant found in a Tourette's syndrome patient.
Biochem. Biophys. Res. Commun. 219:853-858.
Lee, C.-Y., Akera, T., and Brody, T. M. (1977). Effect of Na f , K\ Mg*+ and Ca** on the saturable
binding of ['H]dihydromorphine and ['H]naloxone in vitro. J. Pharmacol. Exp. Ther. 202:166-173.
Lefkowitz, R. J. (1993). G-protein coupled receptors: Turned on to ill effect. Nature 365:604-604.
Limbird, L. E. (1981). Activation and attenuation of adenylate cyclase. The role of GTP-binding proteins
as macromolecular messengers in receptor-cyclase coupling. Biochem. J. 195:1-13.
Lopez-Ibor, J. J. (1988). The involvement of serotonin in psychiatric disorders and behavior. Br. J.
Psychiatry 153 (Suppl. 3):26-39.
Marcinkiewicz, M., Verge, D., Gozlan, H., Pichat, L., and Hamon, M. (1984). Autoradiographic evidence
for the heterogeneity of 5-HT, sites in the rat brain. Brain Res. 291:159-163.
McPherson, G. A. (1985). Analysis of radioligand binding experiments. /. Pharmacol. Meth. 14:213-228.
Middlemiss, D. N., and Fozard, J. R. (1983). 8-Hydroxy-2-(di-n-propylamino)-tetralin discriminates
between subtypes of the 5-HT, recognition site. Eur. J. Pharmacol. 90:151-153.
Mongeau, R., Welner, S. A., Quirion, R., and Suranyi-Cadotte, B. E. (1992). Further evidence for
differential affinity states of the serotonin,A receptor in rat hippocampus. Brain Res. 590:229-238.
Morishima, Y., Nakata, Y., and Segawa, T. (1989). Comparison of the effects of ions and GTP on
substance P binding to membrane-bound and solubilized specific sites. J. Neurochem. 53:1428-1434.
Nenonene, E. K., Radja, F., Cadi, M., Grondin, L., and Reader, T. A. (1994). Heterogeneity of cortical
and hippocampal 5-HT,A receptors: A reappraisal of homogenate binding with 8-['H]hydroxydipro-
pylaminotetralin. J. Neurochem. 62:1822-1834.
Newman-Tancredi, A., Wootton, R., and Strange, P. G. (1992). High-level stable expression of recombi-
nant 5-HT,A 5-hydroxytryptamine receptors in Chinese hamster ovary cells. Biochem. J. 285:933-938.
Ohno, M., and Watanabe, S. (1996). Blockade of 5-HT(A receptors compensates loss of hippocampal
cholinergic neurotransmission involved in working memory of rats. Brain Res. 736:180-188.
Ostrowski, J., Kjelsberg, M. A., Caron, M. G., and Lefkowitz, R. J. (1992). Mutagenesis of the
ft-adrenergic receptor: How structure elucidates function. Annu. Rev. Pharmacol. Toxicol.
32:167-183.
Palacios, J. M., Waeber, C., Hoyer, D., and Mengod, G. (1990). Distribution of serotonin receptors.
Ann. N. Y. Acad. Sci. 600:36-52.
Pasternak, G. W., Snowman, A. M., and Snyder, S. H. (1975). Selective enhancement of ['Hjopiate
agonist binding by divalent cations. Mol. Pharmacol. 11:735-744.
552 Harikumar and Chattopadhyay
Pedigo, N. W., Yamamura, H. I., and Nelson, D. L. (1981). Discrimination of multiple [3H]5-hydroxytryp-
tamine binding sites by the neuroleptic spiperone in rat brain. J. Neurochem. 36:220-226.
Peroutka, S. J. (1988). 5-Hydroxytryptamine receptor subtypes. Anna. Rev. Neurosci. 11:45-60.
Peroutka, S. J. (1993). 5-Hydroxytryptamine receptors. /. Neurochem. 60:408-416.
Peroutka, S. J. (1994). 5-Hydroxytryptamine receptors in vertebrates and invertebrates: Why are there
so many? Neurochem. Int. 25:533-536.
Peroutka, S. J., and Howell, T. A. (1994). The molecular evolution of G protein-coupled receptors:
Focus on 5-hydroxytryptamine receptors. Neurophurmacology 33:319-324.
Peroutka, S. J., and Snyder, S. H. (1979). Multiple serotonin receptors: Differential binding of [3H]5-
hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol. Mol. Pharmacol.
16:687-699.
Quittcrer, U., AbdAlla, S., Jarnagin, K., and Muller-Esterl, W. (1996). Na' ions binding to the bradykinin
B2 receptor suppress agonist-independent receptor activation. Biochemistry 35:13368-13377.
Sadee, W., Pfeiffer, A., and Herz, A. (1982). Opiate receptor: Multiple effects of metal ions. J. Neuro-
chem. 39:659-667.
Saudou, F., and Hen, R. (1994). 5-Hydroxytryptamine receptor subtypes in vertebrates and invertebrates.
Neurochem. Int. 25:503-532.
Saudou, F., Amara, D. A., Dierich, A., LeMeur, M., Ramboz, S., Scgu, L., Buhot, M.-C., and Hen, R.
(1994). Enhanced aggressive behavior in mice lacking 5-HTM1 receptor. Science 265:1875-1878.
Schlegel, J. R., and Peroutka, S. J. (1986). Nucleotide interactions with 5-HT,A binding sites directly
labeled by [•1H]-8-hydroxy-2-(di-n-propylamino)tetralin (['H]-H-OH-DPAT). Biochem. Pharma-
col. 35:1943-1949.
Shiozaki, K., and Haga, T. (1992). Effects of Magnesium ion on the interaction of atrial muscarinic
acetylcholine receptors and GTP-binding regulatory proteins. Biochemistry 31:10634-10642.
Sibley, D. R., and Creese, I. (1983). Regulation of ligand binding to pituitary D-2 dopaminergic receptors:
Effects of divalent cations and functional group modification. J. Biol. Chem. 258:4957-4965.
Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D.,
Fujimoto, E. K., Goeke, N. M., Olson, B. J., and Klenk, D. C. (1985). Measurement of protein
using bicinchoninic acid. Anal. Biochem. 150:76-85.
Strader, C. D., Sigall, I. S., Register, R. B., Candelore, M. R., Rands, E., and Dixon, R. A. F. (1987).
Identification of residues required for ligand binding to the j8-adrenergic receptor. Proc. Nail. Acad.
Sci. USA 84:4384-4388.
Strader, C. D., Fong, T. M., Graziano, M. P., and Tola, M. R. (1995). The family of G-protein-coupled
receptors. FASEB J. 9:745-754.
Strosberg, A. D. (1991). Structure/function relationship of proteins belonging to the family of receptors
coupled to GTP-binding proteins. Eur. J. Biochem. 196:1-10.
Sundaram, H., Newman-Tancredi, A., and Strange, P. G. (1993). Characterization of recombinant human
serotonin 5-HT(A receptors expressed in Chinese hamster ovary cells. Biochem. Pharmacol. 45:1003-
1009.
Sundaram, H., Turner, J. D., and Strange, P. G. (1995). Characterisation of recombinant serotonin
5-HT]A receptors expressed in Chinese hamster ovary cells: The agonist ['Hjlisuride labels free
receptor and receptor coupled to G protein. J. Neurochem. 65:1909-1916.
Sylte, I., Edvardsen, O., and Dahl, S. G. (1993). Molecular dynamics of the 5-HT,d receptor and ligands.
Protein Ens. 6:691-700.
Sylte, I., Edvardsen, O., and Dahl, S. G. (1996). Molecular modelling of UH-301 and 5-HTu receptor
interactions. Protein Eng. 9:149-160.
Tecott, L. H., Sun, L. M., Akana, S. F., Strack, A. M., Lowenstein, D. H., Dallman, M. F., and Julius, D.
(1995). Eating disorder and epilepsy in mice lacking 5-HT,< serotonin receptors. Nature 374:542-546.
Tsai, B. S., and Lefkowitz, R. J. (1978). Agonist-specific effects of monovalent and divalent cations on
adenylate cyclase-coupled alpha adrenergic receptors in rabbit platelets. Mol. Pharmacol.
14:540-548.
U'Prichard, D. C., and Snyder, S. H. (1978). Guanyl nucleotide influences on 'H-ligand binding to
a-noradrenergic receptors in calf brain membranes. J. Biol. Chem. 253:3444-3452.
Verge, D., Daval, G., Marcinkiewicz, M., Patey, A., El-Mestikawy, S., Gozlan, H., and Hamon, M.
(1986). Quantitative autoradiography of multiple 5-HT, receptor subtypes in the brain of control
or 5,7-dihydroxytryptamine-treated rats. /. Neurosci. 6:3474-3482.
Wang, C.-D., Gallaher, T. K., and Shih, J. C. (1993). Site-directed mutagenesis of the serotonin
5-hydroxytryptamine2 receptor: Identification of amino acids necessary for ligand binding and recep-
tor activation. Mol. Pharmacol. 43:931-940.
Werling, L. L., Zarr, G. D., Brown, S. R., and Cox, B. M. (1985). Opioid binding to rat and guinea-pig
Modulation of 5-HTIA Agonist Binding 553
neural membranes in the presence of physiological cations at 37°C. J. Pharmacol. Exp. Ther.
233:722-728.
Werling, L. L., Brown, S. R., Puttfarcken, P., and Cox, B. M. (1986). Sodium regulation of agonist
binding at opioid receptors. II. Effects sodium replacement on opioid binding to guinea-pig cortical
membranes. Mol. Pharmacol. 30:90-95.
Wilkinson, L. O., and Dourish, C. T. (1991). Serotonin and animal behavior. In Peroutka, S. J. (ed.),
Serotonin Receptor Subtypes: Basic and Clinical Aspects, Wiley-Liss, New York, pp. 147-210.
Wreggett, K. A., and De Lean, A. (1984). The ternary complex model: Its properties and application
to ligand interactions with the D2-dopamine receptor of the anterior pituitary gland. Mol. Pharma-
col. 26:214-227.
Yabaluri, N., and Medzihradsky, F. (1997). Regulation of ^ -opioid receptor in neural cells by extracellular
sodium. J. Neurochem. 68:1053-1061.
Yen, S.-R., Fricke, R. A., and Edwards, D. H. (1996). The effect of social experience on serotonergic
modulation of the escape circuit of crayfish. Science 271:366-369.
